The Priority Review

Tag

Type 2 Diabetes Mellitus

1 story

  1. Clinical trials

    Viking Therapeutics registers Phase 3 trial of VK2735 for weight management in type 2 diabetes

    The study plans to enroll 560 participants and is expected to begin on October 16, 2026. It plans to evaluate oral VK2735 for weight management in adults with type 2 diabetes who are obese or overweight.